Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SNX9 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5102325
Description
Antibody detects endogenous levels of total SNX9.
This gene encodes a member of the sorting nexin family. Members of this family contain a phox (PX) domain, which is a phosphoinositide binding domain, and are involved in intracellular trafficking. This protein does not contain a coiled coil region, like some family members, but does contain a SH3 domain near its N-terminus. This protein interacts with the cytoplasmic domains of the precursor but not the processed forms of a disintegrin and metalloprotease domain 9 and 15. This protein binds the beta-appendage domain of adaptor protein 2 and may function to assist adaptor protein 2 in its role at the plasma membrane. This protein interacts with activated Cdc42-associated kinase-2 to regulate the degradation of epidermal growth factor receptor protein.
Specifications
SNX9 | |
Polyclonal | |
Unconjugated | |
Snx9 | |
2700073N08Rik; MST155; MSTP155; OTTHUMP00000040083; Protein SDP1; RP11-266C7.10; SDP1; SH3 and PX domain-containing protein 1; SH3 and PX domain-containing protein 3A; SH3PX1; SH3PXD3A; Snx9; sorting nexin 9; sorting nexin-9; Wiskott-Aldrich syndrome protein (WASP) interactor protein; WISP | |
Rabbit | |
Affinity chromatography | |
RUO | |
51429, 66616, 683687 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
Q91VH2, Q9Y5X1 | |
Snx9 | |
A synthesized peptide derived from human SNX9(Accession Q9Y5X1), corresponding to amino acid residues G429-A479. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction